Phathom Pharmaceuticals Presents Data on Novel Potassium-Competitive Acid Blocker (PCAB) Vonoprazan from a Range of Studies at Digestive Disease Week® (DDW) 2022
Results from an investigational Phase 3 PHALCON-EE trial demonstrating superior healing at week 2 in…